EPIGENETIC MARKERS FOR THE TREATMENT OF BREAST CANCER

摘要

The present invention provides novel epigenetic markers with utility in the treatment of breast cancer. The markers enable the prediction of nodal status, estrogen receptor status and progesterone receptor status in breast cancer patients. Accurate prediction and monitoring of said parameters enables the clinician to recommend suitable therapies.